Effect of switching from conventional continuous subcutaneous insulin infusion to sensor augmented pump therapy on glycemic profile in Japanese patients with type 1 diabetes

AIMS: Evidence suggests that sensor augmented pump (SAP) therapy is superior to conventional continuous subcutaneous insulin infusion (CSII) for achieving glycemic control in patients with type 1 diabetes. However, the clinical benefit of SAP therapy in East Asians has not yet been demonstrated. MET...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetol Int
Autors principals: Matsuoka, Atsuko, Hirota, Yushi, Urai, Shin, Hamaguchi, Tetsushi, Takeuchi, Takehito, Miura, Hiroshi, Suematsu, Natsu, So, Anna, Nakamura, Tomoaki, Komada, Hisako, Okada, Yuko, Sakaguchi, Kazuhiko, Ogawa, Wataru
Format: Artigo
Idioma:Inglês
Publicat: Springer Japan 2018
Matèries:
Short Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6224909/
https://ncbi.nlm.nih.gov/pubmed/30603368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13340-018-0344-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars